Polypoidal Choroidal Vasculopathy: Recent advances in therapy

G. de Crecchio, R. V P Chan, G. Manzi, M. R. Romano

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Polypoidal Choroidal Vasculopathy (PCV) is a condition characterized by chronic, multiple, recurrent serous and/or hemorrhagic detachments of the retinal pigment epithelium (RPE) and neurosensory retina. Although it has been described to more often affect Asians and individuals of pigmented races, PCV may also be present in white patients who present with the clinical appearance of age related macular degeneration (AMD). PCV and its treatment are discussed, including the use of combination therapy.

Original languageEnglish
Pages (from-to)206-211
Number of pages6
JournalCurrent Drug Targets
Volume12
Issue number2
DOIs
Publication statusPublished - Jul 2012

Fingerprint

Retinal Pigments
Retinal Pigment Epithelium
Macular Degeneration
Retina
Therapeutics
Multiple Chronic Conditions

Keywords

  • Age-related macular degeneration
  • AntiVEGF
  • Choroidal neovascularization
  • Combination therapy
  • Photodynamic therapy
  • Polypoidal choroidal vasculopathy
  • Triamcinolone

ASJC Scopus subject areas

  • Drug Discovery
  • Pharmacology
  • Clinical Biochemistry
  • Molecular Medicine

Cite this

de Crecchio, G., Chan, R. V. P., Manzi, G., & Romano, M. R. (2012). Polypoidal Choroidal Vasculopathy: Recent advances in therapy. Current Drug Targets, 12(2), 206-211. https://doi.org/10.2174/138945011794182782

Polypoidal Choroidal Vasculopathy : Recent advances in therapy. / de Crecchio, G.; Chan, R. V P; Manzi, G.; Romano, M. R.

In: Current Drug Targets, Vol. 12, No. 2, 07.2012, p. 206-211.

Research output: Contribution to journalArticle

de Crecchio, G, Chan, RVP, Manzi, G & Romano, MR 2012, 'Polypoidal Choroidal Vasculopathy: Recent advances in therapy', Current Drug Targets, vol. 12, no. 2, pp. 206-211. https://doi.org/10.2174/138945011794182782
de Crecchio, G. ; Chan, R. V P ; Manzi, G. ; Romano, M. R. / Polypoidal Choroidal Vasculopathy : Recent advances in therapy. In: Current Drug Targets. 2012 ; Vol. 12, No. 2. pp. 206-211.
@article{900351c4191a44f0993949f2ec321c00,
title = "Polypoidal Choroidal Vasculopathy: Recent advances in therapy",
abstract = "Polypoidal Choroidal Vasculopathy (PCV) is a condition characterized by chronic, multiple, recurrent serous and/or hemorrhagic detachments of the retinal pigment epithelium (RPE) and neurosensory retina. Although it has been described to more often affect Asians and individuals of pigmented races, PCV may also be present in white patients who present with the clinical appearance of age related macular degeneration (AMD). PCV and its treatment are discussed, including the use of combination therapy.",
keywords = "Age-related macular degeneration, AntiVEGF, Choroidal neovascularization, Combination therapy, Photodynamic therapy, Polypoidal choroidal vasculopathy, Triamcinolone",
author = "{de Crecchio}, G. and Chan, {R. V P} and G. Manzi and Romano, {M. R.}",
year = "2012",
month = "7",
doi = "10.2174/138945011794182782",
language = "English",
volume = "12",
pages = "206--211",
journal = "Current Drug Targets",
issn = "1389-4501",
publisher = "Bentham Science Publishers B.V.",
number = "2",

}

TY - JOUR

T1 - Polypoidal Choroidal Vasculopathy

T2 - Recent advances in therapy

AU - de Crecchio, G.

AU - Chan, R. V P

AU - Manzi, G.

AU - Romano, M. R.

PY - 2012/7

Y1 - 2012/7

N2 - Polypoidal Choroidal Vasculopathy (PCV) is a condition characterized by chronic, multiple, recurrent serous and/or hemorrhagic detachments of the retinal pigment epithelium (RPE) and neurosensory retina. Although it has been described to more often affect Asians and individuals of pigmented races, PCV may also be present in white patients who present with the clinical appearance of age related macular degeneration (AMD). PCV and its treatment are discussed, including the use of combination therapy.

AB - Polypoidal Choroidal Vasculopathy (PCV) is a condition characterized by chronic, multiple, recurrent serous and/or hemorrhagic detachments of the retinal pigment epithelium (RPE) and neurosensory retina. Although it has been described to more often affect Asians and individuals of pigmented races, PCV may also be present in white patients who present with the clinical appearance of age related macular degeneration (AMD). PCV and its treatment are discussed, including the use of combination therapy.

KW - Age-related macular degeneration

KW - AntiVEGF

KW - Choroidal neovascularization

KW - Combination therapy

KW - Photodynamic therapy

KW - Polypoidal choroidal vasculopathy

KW - Triamcinolone

UR - http://www.scopus.com/inward/record.url?scp=79955654604&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79955654604&partnerID=8YFLogxK

U2 - 10.2174/138945011794182782

DO - 10.2174/138945011794182782

M3 - Article

C2 - 20887241

AN - SCOPUS:79955654604

VL - 12

SP - 206

EP - 211

JO - Current Drug Targets

JF - Current Drug Targets

SN - 1389-4501

IS - 2

ER -